Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lymphocytapheresis

Y Takenaka1

  • 1Asahi Medical Company, Ltd., Tokyo, Japan.

Artificial Organs
|August 1, 1996
PubMed
Summary
This summary is machine-generated.

The Cellsorba filter removes leukocytes during extracorporeal circulation, offering a new treatment for autoimmune diseases like rheumatoid arthritis and inflammatory bowel diseases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Changes in the composition of molecular species of covalently bound and free ceramides [EOS], and their correlation with disease severity in atopic dermatitis.

Experimental dermatology·2024
Same author

Ischaemic skin ulcers with neurofibromatosis 1 successfully treated with stent implantation.

Clinical and experimental dermatology·2021
Same author

Light-induced displacement of a microbead through the thermal expansion of liquid crystals.

Soft matter·2016
Same author

Royal Jelly from Apis cerana japonica and Apis mellifera.

Bioscience, biotechnology, and biochemistry·2016
Same author

Dewetting of a droplet induced by the adsorption of surfactants on a glass substrate.

Soft matter·2014
Same author

CD10 as a novel marker of therapeutic resistance and cancer stem cells in head and neck squamous cell carcinoma.

British journal of cancer·2014

Area of Science:

  • Immunology
  • Medical Technology
  • Gastroenterology

Background:

  • Leukocytapheresis traditionally uses centrifugal methods.
  • The Cellsorba filter, developed in Japan in 1989, offers an alternative extracorporeal leukocyte removal technique.
  • This filter utilizes non-woven fabric to remove leukocytes from whole blood.

Purpose of the Study:

  • To describe the Cellsorba filter and its applications.
  • To highlight the evolving use of leukocyte removal filters in treating various diseases.

Main Methods:

  • Extracorporeal circulation with a non-woven fabric filter (Cellsorba).
  • Application of the filter in treating collagen diseases, rheumatoid arthritis, and systemic lupus erythematosus.
  • Observational studies on the filter's efficacy in autoimmune and inflammatory bowel diseases.

Related Experiment Videos

Main Results:

  • Cellsorba effectively removes leukocytes during extracorporeal circulation.
  • The filter demonstrates an immunosuppressive effect.
  • Successful application in collagen diseases, rheumatoid arthritis, systemic lupus erythematosus, and inflammatory bowel diseases (ulcerative colitis, Crohn's disease).

Conclusions:

  • Cellsorba represents an advancement in leukocyte removal technology.
  • The filter shows significant therapeutic potential for autoimmune and inflammatory bowel diseases.
  • Ongoing research continues to expand the clinical applications of Cellsorba.